MENU
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NewAmsterdam Pharma (NAMS) Ownership - Who owns NewAmsterdam Pharma?

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

Profile

Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
100
Web
https://www.newamsterdampharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.6B
P/E Ratio
N/A
Total Cash
636.11M
Projected Growth
N/A
Total Debt
23K
Revenue
22.57M
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash/Share
5.44
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
View a ticker or compare two or three
NAMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
100
Web
https://www.newamsterdampharma.com